In the present study, the serum levels of most of the analyzed chemokines and growth factors (excluding MCP-1, MIP-1β, RANTES, and GRO-α) were significantly higher (p<0.05) in COVID-19 patients than in the control group. This evidence concerns the gene CXCL1 and COVID-19.